Predictive value of left atrial appendage hemodynamics for left atrial appendage thrombus in patients with nonvalvular atrial fibrillation by transesophageal echocardiography
Yuanyuan MA,Yanyan JIA,Hongning SONG,Bo HU,Lan ZHANG,Tuantuan TAN,Jinling CHEN,Qing ZHOU,Ruiqiang GUO
DOI: https://doi.org/10.3969/j.issn.1008-6978.2017.12.005
2017-01-01
Abstract:Objective To explore the value of transesophageal echocardiography(TEE)in evaluating left atrial appendage (LAA) hemodynamics and predicting LAA thrombus in patients with nonvalvular atrial fibrillation.Methods One hundred and thirty-eight atrial fibrillation patients and 30 controls were enrolled in this study.At the 2D-TEE mid-esophageal views,LAA flow spectra and tissue velocity imaging of 0°,45°,90° and 135° were obtained respectively.LAA ejection fraction(LAAEF),LAA maximal volume(LAAVmax),LAA filling peak flow velocity(LAA-FV),LAA emptying peak flow velocity(LAA-EV),LAA average filling flow velocity(LAA-AFV),LAA average emptying flow velocity(LAA-AEV),LAA walls systolic peak velocity (LAA-SV) and diastolic peak velocity(LAA-DV) were measured . The above indicators were compared in two groups . Results Compared to the control group,LAA-EV,LAA-AEV,LAA-FV,LAA-AFV and LAAEF were lower and LAAVmax were higher in atrial fibrillation group(all P<0 . 05). Among 138 atrial fibrillation patients , there were 15 patients with LAA thrombus,and 123 patients without thrombus.LAA-AEV,LAA-AFV,LAAEF,LAA-SV and LAA-DV gradually reduced among controls,patients without thrombus and with thrombus.The cut-off values of LAA-AFV and LAA-AEV in diagnosis of LAAthrombus were 27.5 cm/s and 33.0 cm/s respectively,specificity were 73.3% and 80.0%,sensitivity were 96.7% and 86.7%, respectively.Conclusion TEE can effectively reflect LAA hemodynamics and function.The LAA systolic and diastolic function of nonvalvular atrial fibrillation patients are lower,and even worse in those with thrombus.LAA-AEV and LAA-AFV are good parameters which can provide more references for predicting LAA thrombus in nonvalvular atrial fibrillation patients.